Quick Links
  • ASMS

    美国质谱学会

  • CMSS

    中国质谱学会

  • TSMS

    台灣質譜學會

  • HKSMS

    香港质谱学会

Home>About CASMS>Digital Communications Committee

The Digital Communications Committee

  • Co-Chair:Qibin Zhang

    Dr. Zhang is an Associate Professor in the Department of Chemistry and Biochemistry, and Co-Director of the Center for Translational Biomedical Research at the University of North Carolina at Greensboro (UNCG), North Carolina, U.S.A. With multiple grants support from the National

    Institutes of Health and the American Heart Association, the Zhang lab is focused on development of advanced mass spectrometric analysis tools and clinical applications of proteomics, lipidomics and metabolomics in Type 1 Diabetes and cardiovascular diseases resulted from diabetic complications.Dr. Zhang obtained his PhD degree from the University of California at Riverside, followed by postdoctoral studies in proteomics and metabolomics at the Pacific Northwest National Laboratory (PNNL), U.S. Department of Energy. He started his independent research career at PNNL as a Scientist and moved to the current position at UNCG in 2014.

    More >>
  • Co-Chair: Xiaorong Liang

    Dr. Xiaorong Liang is currently the head of small molecule regulated bioanalytics at Genentech in South San Francisco, California, USA. He obtained his Ph.D. degree in

    analytical chemistry from Purdue University under the supervision of Prof. Scott McLuckey. Xiaorong has over 12 years of industry experience working on the bioanalytical method development, validation, and sample analysis. He leads a group of scientific staff supporting all the small molecule drug development projects and also manages metabolomics group at Genentech. He represents Genentech at the IQ consortium for dried blood spot and ICH M10 working groups. He also serves as a reviewer for various journals in the bioanalytical field. He has published 50 peer-reviewed papers on various top journals in the (bio)analytical field. His publication has been cited more than 1000 times and his h-index is 18.

    More >>
     
  • Member:Yan Wang(Past-Co-Chair)

    Dr. Yan Wang got her Ph.D. in Medicinal Chemistry from University of Illinois at Chicago in 2001. After that, she built a career in academic core facilities, starting at the Mass Spectrometry Facility at UIC after graduation. In 2008, Dr. Wang moved to University of Maryland College

    Park to establish a new proteomics core facility there. Most recently in 2019 she started a new position at NIH/NIDCR to build a new mass spectrometry facility, again focusing on proteomics.In addition to being a long time ASMS member and supporter of CASMS. Dr. Wang is active in the Association of Biomolecular Resource Facilities (ABRF). She has been an active member of the Proteomics Research Group since 2014, including two years serving as chair the Group.

    More >>
  • Member:Jinlan Dong

    Dr. Jinlan Dong is currently a Research Investigator in the Metabolism and Analytical group at Corteva Agriscience in Newark, Delaware, USA. Jinlan received her Ph.D. degree in Analytical Chemistry from Michigan State University in 2014 and conducted her postdoctoral research at the

    U.S. Food and Drug Administration. In 2015, she joined QPS LLC in Newark, Delaware, where she worked on LC-MS/MS method development and validation for small molecules to support preclinical and clinical projects. She then moved to Corteva Agriscience in 2019. In her current position, she serves as the lead principal investigator for bioanalysis of small molecules for both in vitro and in vivo studies in the pipeline. Jinlan’s primary research focuses on development of high-throughput bioanalytical methods in support of different types of regulatory studies. She is also a reviewer for multiple analytical and bioanalytical journals. 

    More >>
  • Member:Yonghao Yu(Past-Co-Chair)

    Dr. Yu received his undergraduate degree in chemistry from Fudan University (Shanghai, China) in 2001. He came to the U.S. and received his Ph.D. in Chemistry from the University of California, Berkeley in 2006 under the direction of Julie Leary, where he developed mass spectrometric approaches for the study of protein-ligand interactions. As a graduate student, he also developed a series of proteomic technologies for the study of tyrosine sulfation, a protein post-translational

    modification that is implicated in regulating protein-protein interactions in the extracellular space. In 2007, Dr. Yu joined the laboratories of Steven Gygi and John Blenis in the Department of Cell Biology at Harvard Medical School for his post-doctoral training. There he developed quantitative mass spectrometric strategies for the study of protein phosphorylation. He deployed these powerful technologies to characterize the PI3K/Akt/mTORC1 pathway, and identified their downstream signaling modules that control a variety of cellular anabolic processes.   In 2012, Dr. Yu began his independent research career as an Assistant Professor in the Department of Biochemistry at UT Southwestern Medical Center. He was promoted to Associate Professor with tenure in 2017. Throughout his career, Dr. Yu has been the recipient of numerous awards for his research, including the Tuberous Sclerosis Alliance Postdoctoral Fellowship, a CPRIT Scholar in Cancer Research award, a Virginia Murchison Linthicum Scholar in Medical Research award, a Research Scholar award from the American Cancer Society and a UT System Rising STARs Award. The long-term goals of the Yu lab are to develop cutting-edge, mass spectrometry-based proteomic technologies, and applying them to systematically characterize protein modification events implicated in various pathophysiological conditions. These data-driven strategies are then combined with classical biochemistry approaches to identify aberrant protein modification patterns, decipher the mechanisms of their deregulation, establish the functional consequences of these molecular events, facilitate the development of relevant therapeutic strategies, and finally, identify proteomic signatures that may serve as diagnostic, prognostic or predictive biomarkers for the relevant diseases. 

    More >>
Level of Sponsorship

Platinum Sponsors

Gold Sponsors

Silver Sponsors

Copper Sponsors